Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Participants received a subcutaneous injection of 2.4 mg of semaglutide (or placebo) per week, which is similar to the way that diabetic patients inject insulin
PlexusDx asks you to log and share these readings at each check-in so clinicians can spot trends early
Semaglutide is beneficial as a treatment option for type 2 diabetes: Lower Blood Sugar Levels: Semaglutide helps regulate blood sugar levels by increasing insulin secretion and reducing glucagon production, leading to improved glycemic control [7]
NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure
Diabetic retinopathy - semaglutide If you have diabetic eye disease and use insulin, rapid improvement in blood sugar control can temporarily worsen your vision
